dc.contributor.author
Pavlenko, Elena
dc.contributor.author
Strech, Daniel
dc.contributor.author
Langhof, Holger
dc.date.accessioned
2020-11-30T11:47:23Z
dc.date.available
2020-11-30T11:47:23Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/28977
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-28727
dc.description.abstract
Background: The promises of improved health care and health research through data-intensive applications rely on a growing amount of health data. At the core of large-scale data integration efforts, clinical data warehouses (CDW) are also responsible for data governance, managing data access and (re)use. As the complexity of the data flow increases, greater transparency and standardization of criteria and procedures are required in order to maintain objective oversight and control. Therefore, the development of practice oriented and evidence-based policies is crucial. This study assessed the spectrum of data access and use criteria and procedures in clinical data warehouses governance internationally.
Methods: We performed a systematic review of (a) the published scientific literature on CDW and (b) publicly available information on CDW data access, e.g., data access policies. A qualitative thematic analysis was applied to all included literature and policies.
Results: Twenty-three scientific publications and one policy document were included in the final analysis. The qualitative analysis led to a final set of three main thematic categories: (1) requirements, including recipient requirements, reuse requirements, and formal requirements; (2) structures and processes, including review bodies and review values; and (3) access, including access limitations.
Conclusions: The description of data access and use governance in the scientific literature is characterized by a high level of heterogeneity and ambiguity. In practice, this might limit the effective data sharing needed to fulfil the high expectations of data-intensive approaches in medical research and health care. The lack of publicly available information on access policies conflicts with ethical requirements linked to principles of transparency and accountability. CDW should publicly disclose by whom and under which conditions data can be accessed, and provide designated governance structures and policies to increase transparency on data access. The results of this review may contribute to the development of practice-oriented minimal standards for the governance of data access, which could also result in a stronger harmonization, efficiency, and effectiveness of CDW.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Clinical data warehouse
en
dc.subject
Data access and use
en
dc.subject
Data sharing
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Implementation of data access and use procedures in clinical data warehouses. A systematic review of literature and publicly available policies
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
157
dcterms.bibliographicCitation.doi
10.1186/s12911-020-01177-z
dcterms.bibliographicCitation.journaltitle
BMC Medical Informatics and Decision Making
dcterms.bibliographicCitation.originalpublishername
BMC
dcterms.bibliographicCitation.volume
20
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
32652989
dcterms.isPartOf.eissn
1472-6947